ea0032p92 | Bone and Osteoporosis | ECE2013
Anagnostis Panagiotis
, Vyzantiadis Tomoleon-Achilleas
, Charizopoulou Maria
, Adamidou Fotini
, Karras Spyridon
, Slavakis Arisitidis
, Garipidou Vasilia
, Vakalopoulou Sofia
Introduction: Haemophilia A and B has been associated with increased prevalence of low bone mineral density (BMD). However, no study has so far evaluated the effects of anti-osteoporotic therapy on BMD.Methods/design: The primary endpoint of this prospective study was to estimate the effect of 12-month therapy of oral ibandronate 150 mg/month on BMD in patients with haemophilia A and B. Secondary endpoint was its effect on bone turnover markers (BTM), in...